Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

In vitro measurement of skin sensitization hazard of mixtures and finished products: Results obtained with the SENS-IS assays.

Cottrez F, Boitel E, Berrada-Gomez MP, Dalhuchyts H, Bidan C, Rattier S, Ferret PJ, Groux H.

Toxicol In Vitro. 2020 Feb;62:104644. doi: 10.1016/j.tiv.2019.104644. Epub 2019 Sep 10.

PMID:
31518668
2.

Cutting Edge: Nrf2 Regulates Neutrophil Recruitment and Accumulation in Skin during Contact Hypersensitivity.

Helou DG, Noël B, Gaudin F, Groux H, El Ali Z, Pallardy M, Chollet-Martin S, Kerdine-Römer S.

J Immunol. 2019 Apr 15;202(8):2189-2194. doi: 10.4049/jimmunol.1801065. Epub 2019 Mar 8.

PMID:
30850475
3.

The THP-1 cell toolbox: a new concept integrating the key events of skin sensitization.

Clouet E, Bechara R, Raffalli C, Damiens MH, Groux H, Pallardy M, Ferret PJ, Kerdine-Römer S.

Arch Toxicol. 2019 Apr;93(4):941-951. doi: 10.1007/s00204-019-02416-7. Epub 2019 Feb 26.

PMID:
30806763
4.

SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: Reproducibility and predictivity results from an inter-laboratory study.

Cottrez F, Boitel E, Ourlin JC, Peiffer JL, Fabre I, Henaoui IS, Mari B, Vallauri A, Paquet A, Barbry P, Auriault C, Aeby P, Groux H.

Toxicol In Vitro. 2016 Apr;32:248-60. doi: 10.1016/j.tiv.2016.01.007. Epub 2016 Jan 18.

PMID:
26795242
5.

Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.

Cottrez F, Boitel E, Auriault C, Aeby P, Groux H.

Toxicol In Vitro. 2015 Jun;29(4):787-802. doi: 10.1016/j.tiv.2015.02.012. Epub 2015 Feb 24.

PMID:
25724174
6.

Systematic evaluation of non-animal test methods for skin sensitisation safety assessment.

Reisinger K, Hoffmann S, Alépée N, Ashikaga T, Barroso J, Elcombe C, Gellatly N, Galbiati V, Gibbs S, Groux H, Hibatallah J, Keller D, Kern P, Klaric M, Kolle S, Kuehnl J, Lambrechts N, Lindstedt M, Millet M, Martinozzi-Teissier S, Natsch A, Petersohn D, Pike I, Sakaguchi H, Schepky A, Tailhardat M, Templier M, van Vliet E, Maxwell G.

Toxicol In Vitro. 2015 Feb;29(1):259-70.

7.

Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation.

Carpentier A, Conti F, Stenard F, Aoudjehane L, Miroux C, Podevin P, Morales O, Chouzenoux S, Scatton O, Groux H, Auriault C, Calmus Y, Pancre V, Delhem N.

Am J Transplant. 2009 Sep;9(9):2102-12. doi: 10.1111/j.1600-6143.2009.02743.x. Epub 2009 Jul 16.

8.

Analysis of gene transcription in sera during chronic hepatitis C infection.

Carpentier A, Conti F, Carrière M, Aoudjehane L, Miroux C, Moralès O, Calmus Y, Groux H, Auriault C, Pancré V, Delhem N, Podevin P.

J Med Virol. 2009 Mar;81(3):473-80. doi: 10.1002/jmv.21398.

PMID:
19152403
9.

[Regulatory T-cells and hepatocellular carcinoma: implication of the regulatory T lymphocytes in the control of the immune response].

Delhem N, Carpentier A, Moralès O, Miroux C, Groux H, Auriault C, Pancré V.

Bull Cancer. 2008 Dec;95(12):1219-25. doi: 10.1684/bdc.2008.0761. Review. French.

10.

[Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].

Delhem N, Cottrez F, Carpentier A, Miroux C, Moralès O, François V, Groux H, Auriault C, Pancré V.

Bull Cancer. 2008 Nov;95(11):1029-38. doi: 10.1684/bdc.2008.0752. French.

11.

Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.

Dalmasso G, Cottrez F, Imbert V, Lagadec P, Peyron JF, Rampal P, Czerucka D, Groux H, Foussat A, Brun V.

Gastroenterology. 2006 Dec;131(6):1812-25. Erratum in: Gastroenterology. 2007 Apr;132(4):1637. Foussat, Arnaud [added]; Brun, Valerie [added].

PMID:
17087945
12.

Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity.

Rahmoun M, Foussat A, Groux H, Pène J, Yssel H, Chanez P.

Int Arch Allergy Immunol. 2006;140(2):139-49. Epub 2006 Apr 4.

PMID:
16601351
13.

Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse.

Rodriguez AM, Pisani D, Dechesne CA, Turc-Carel C, Kurzenne JY, Wdziekonski B, Villageois A, Bagnis C, Breittmayer JP, Groux H, Ailhaud G, Dani C.

J Exp Med. 2005 May 2;201(9):1397-405.

14.

Live Staphylococcus aureus and bacterial soluble factors induce different transcriptional responses in human airway cells.

Moreilhon C, Gras D, Hologne C, Bajolet O, Cottrez F, Magnone V, Merten M, Groux H, Puchelle E, Barbry P.

Physiol Genomics. 2005 Feb 10;20(3):244-55. Epub 2004 Dec 14.

15.

Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice.

Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, Tedgui A, Mallat Z.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1474-8. Epub 2004 Jun 3.

PMID:
15178562
16.

Role of dendritic cells in the generation of regulatory T cells.

Groux H, Fournier N, Cottrez F.

Semin Immunol. 2004 Apr;16(2):99-106. Review.

PMID:
15036233
17.

Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells.

Cottrez F, Groux H.

Transplantation. 2004 Jan 15;77(1 Suppl):S12-5. Review.

PMID:
14726762
18.

Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.

Silvestre JS, Gojova A, Brun V, Potteaux S, Esposito B, Duriez M, Clergue M, Le Ricousse-Roussanne S, Barateau V, Merval R, Groux H, Tobelem G, Levy B, Tedgui A, Mallat Z.

Circulation. 2003 Dec 9;108(23):2839-42. Epub 2003 Dec 1.

PMID:
14656923
19.

A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation.

Foussat A, Cottrez F, Brun V, Fournier N, Breittmayer JP, Groux H.

J Immunol. 2003 Nov 15;171(10):5018-26.

20.

Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice.

Mallat Z, Gojova A, Sauzeau V, Brun V, Silvestre JS, Esposito B, Merval R, Groux H, Loirand G, Tedgui A.

Circ Res. 2003 Oct 31;93(9):884-8. Epub 2003 Oct 2.

PMID:
14525807
21.

Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice.

Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, Ardouin P, Tedgui A, Mallat Z, Groux H.

Blood. 2003 Dec 1;102(12):4052-8. Epub 2003 Aug 14.

PMID:
12920022
22.

Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.

Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, Tedgui A, Groux H.

Circulation. 2003 Sep 9;108(10):1232-7. Epub 2003 Aug 11.

PMID:
12912803
23.

Type 1 T-regulatory cells: their role in the control of immune responses.

Groux H.

Transplantation. 2003 May 15;75(9 Suppl):8S-12S.

PMID:
12819483
24.

The complex role of interleukin-10 in autoimmunity.

Groux H, Cottrez F.

J Autoimmun. 2003 Jun;20(4):281-5. Review.

PMID:
12791313
25.

Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H.

Immunity. 2003 May;18(5):605-17.

26.

Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.

Philippe D, Dubuquoy L, Groux H, Brun V, Chuoï-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, Desreumaux P.

J Clin Invest. 2003 May;111(9):1329-38.

27.

Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.

Masy E, Adriaenssens E, Montpellier C, Crépieux P, Mougel A, Quatannens B, Goormachtigh G, Faumont N, Meggetto F, Auriault C, Groux H, Coll J.

J Virol. 2002 Jul;76(13):6460-72.

28.

An overview of regulatory T cells.

Groux H.

Microbes Infect. 2001 Sep;3(11):883-9. Review.

PMID:
11564435
29.

Differentiation of regulatory T cells 1 is induced by CD2 costimulation.

Wakkach A, Cottrez F, Groux H.

J Immunol. 2001 Sep 15;167(6):3107-13.

30.
31.

T regulatory cells 1 inhibit a Th2-specific response in vivo.

Cottrez F, Hurst SD, Coffman RL, Groux H.

J Immunol. 2000 Nov 1;165(9):4848-53.

32.

Can interleukin-10 be used as a true immunoregulatory cytokine?

Wakkach A, Cottrez F, Groux H.

Eur Cytokine Netw. 2000 Jun;11(2):153-60. Review.

33.

Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases.

Yssel H, Groux H.

Int Arch Allergy Immunol. 2000 Jan;121(1):10-8. Review.

PMID:
10686504
34.

Regulatory T cells and inflammatory bowel disease.

Groux H, Powrie F.

Immunol Today. 1999 Oct;20(10):442-5. Review.

PMID:
10500290
35.

IL-10 transgenic mice present a defect in T cell development reminiscent of SCID patients.

Rouleau M, Cottrez F, Bigler M, Antonenko S, Carballido JM, Zlotnik A, Roncarolo MG, Groux H.

J Immunol. 1999 Aug 1;163(3):1420-7.

36.

Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis.

Cua DJ, Groux H, Hinton DR, Stohlman SA, Coffman RL.

J Exp Med. 1999 Mar 15;189(6):1005-10.

37.

A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells.

Groux H, Cottrez F, Rouleau M, Mauze S, Antonenko S, Hurst S, McNeil T, Bigler M, Roncarolo MG, Coffman RL.

J Immunol. 1999 Feb 1;162(3):1723-9.

38.

Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells.

Groux H, Bigler M, de Vries JE, Roncarolo MG.

J Immunol. 1998 Apr 1;160(7):3188-93.

39.

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG.

Nature. 1997 Oct 16;389(6652):737-42.

PMID:
9338786
40.

Homologous T and B cells immortalized in vitro by the Epstein-Barr virus exhibit differential genetical and functional features.

Montpellier C, Crepieux P, Quatannens B, Delobel B, Croquette M, Stehelin D, Auriault C, Groux H, Coll J.

Int J Oncol. 1997 Jul;11(1):87-96.

PMID:
21528184
41.

Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus.

Groux H, Cottrez F, Montpellier C, Quatannens B, Coll J, Stehelin D, Auriault C.

Blood. 1997 Jun 15;89(12):4521-30.

PMID:
9192776
42.

Induction of human T helper cell type 1 differentiation results in loss of IFN-gamma receptor beta-chain expression.

Groux H, Sornasse T, Cottrez F, de Vries JE, Coffman RL, Roncarolo MG, Yssel H.

J Immunol. 1997 Jun 15;158(12):5627-31.

PMID:
9190910
43.

Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule.

Cottrez F, Manca F, Dalgleish AG, Arenzana-Seisdedos F, Capron A, Groux H.

J Clin Invest. 1997 Jan 15;99(2):257-66.

45.

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Groux H, Bigler M, de Vries JE, Roncarolo MG.

J Exp Med. 1996 Jul 1;184(1):19-29.

46.

T-cell subsets and their cytokine profiles in transplantation and tolerance.

Groux H, Rouleau M, Bacchetta R, Roncarolo MG.

Ann N Y Acad Sci. 1995 Dec 29;770:141-8. Review. No abstract available.

PMID:
8597356
47.

Murine interleukin-4 production with baculovirus: an easy and rapid method for a small scale production of functional interleukins.

Cottrez F, Auriault C, Capron A, Kusznier JP, Groux H.

Eur Cytokine Netw. 1994 Sep-Oct;5(5):481-7.

PMID:
7880979
48.

Quantitative PCR: validation of the use of a multispecific internal control.

Cottrez F, Auriault C, Capron A, Groux H.

Nucleic Acids Res. 1994 Jul 11;22(13):2712-3. No abstract available.

49.
50.

Role of HIV-1 Nef expression in activation pathways in CD4+ T cells.

Carreer R, Groux H, Ameisen JC, Capron A.

AIDS Res Hum Retroviruses. 1994 May;10(5):523-7.

PMID:
7917514

Supplemental Content

Support Center